Impaired IgG antibody production to pneumococcal polysaccharides in patients with ataxia-telangiectasia

Journal of Clinical Immunology

Volumn 19, Issue 5, 1999, Pages 326-334

  Sanal, O ^a   Ersoy, F ^a   Yel, L ^a,b   Tezcan, I ^a   Metin, A ^a   Ozyurek H ^a   Gariboglu, S ^a   Fikrig, S ^c   Berkel, A I ^a   Rijkers, G T ^d   Zegers, B J M ^d  

^a HACETTEPE UNIVERSITY   (Turkey)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c SUNY DOWNSTATE MEDICAL CENTER   (United States)

^d UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Antibody; Ataxia telangiectasia; IgA; IgG subclass; Pneumococcal polysaccharides

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; PNEUMOCOCCUS POLYSACCHARIDE; PNEUMOCOCCUS VACCINE; TETANUS TOXOID;

ADOLESCENT; ADULT; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; ATAXIA TELANGIECTASIA; B LYMPHOCYTE; BRONCHIECTASIS; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GRAVIMETRY; HUMAN; INFECTION SENSITIVITY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; T LYMPHOCYTE;

ADOLESCENT; ADULT; ANTIBODIES, BACTERIAL; ATAXIA TELANGIECTASIA; BACTERIAL VACCINES; CHILD; CHILD, PRESCHOOL; DISEASE SUSCEPTIBILITY; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN ISOTYPES; OPPORTUNISTIC INFECTIONS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; RESPIRATORY TRACT INFECTIONS; STREPTOCOCCUS PNEUMONIAE;

EID: 0032834595     PISSN: 02719142     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020599810261     Document Type: Article

References (40)

1. 1. Sedgwick RP, Boder E: Ataxia telangiectasia. In Handbook of Clinical Neurology, Vol 16. Hereditary Neuropathies and Spinocerebellar Atrophies. JMBV de long (ed). Amsterdam, Elsevier, 1991, pp 347-423
2. 2. West CD: IgA deficiency and susceptibility to infection. J Pediatr 73:644-645, 1968
3. 3. Sanal O, Ozaltin F, Tezcan I, Ersoy F: Serum IgD concentrations in patients with ataxia-telangiectasia and with selective IgA deficiency. Int Arch Allergy lmmunol 116:246, 1998
4. 4. Ammann A J, Cain WA, Izhizaka K, Hong R, Good RA: Immunoglobulin E deficiency in ataxia-telangiectasia. N Eng J Med 281:469-472, 1969
5. 5. Oxelius VA, Berkel AI, Hansun LA: Immunoglobulin G2 deficiency in ataxia-telangiectasia. N Engl J Med 306:515-517, 1982
6. 6. Aucouturier P, Bremard-Oury, Gricelli C, Berthier M, Preud'homme JL: Serum IgG subclass deficiency in ataxia-telangiectasia. Clin Exp Immunol 68:392-396, 1987
7. 7. Shuster J, Hart Z, Stimson CW, Brough AJ, Poulik MD: Ataxia-telangiectasia with cerebellar tumor. Pediatrics 37:776-786, 1966
8. 8. Yarchoan R, Kurman CC, Nelson DL: Defective specific antiinfluenza virus antibody production in vitro by lymphocytes from patienis with ataxia-telangiectasia. Kroc Found Ser 19:315-329, 1985
9. 9. Weemaes CM, The TH, van Munster PJ, Bakkaren JA: Antibody responses in vivo in chromosome instability syndromes with immunodeficiency. Clin. Exp Immunol 57:529-534, 1984
10. 10. Biggar WD, Good RA: Immunodeficiency in ataxia-telangiectasia. Birth Defects Orig Art Ser 11:271-276, 1975
11. 11. Rigas DA, Tisdale VV, Hecht F: Transformation of blood lymphocytes in ataxia-telangiectasia. Dose and time response to phytohemagglutinin. Int Arch Allergy Appl Immunol 39:221-233, 1970
12. 12. Levis WR, Dattner AM, Shaw S: Selective defects in T cell function in ataxia-telangicetasia. Clin Exp Immunol 37:44-49, 1979
13. 13. Nelson DL, Biddison WE, Shaw S: Defective in vitro production of influenza virus-specific cytotoxic T lymphocytes in ataxia-telangiectasia. J Immunol 130:2629-2634, 1983
14. 14. Roifman CM, Gelfand EW: Heterogeneity of the immunological deficiency in ataxia-telangiectasia: Absence of a clinical-pathological correlation. In Ataxia-Telangiectasia, RA Gatti, M Swift (eds). New York, Alan R Liss, 1985, pp 273-285
15. 15. Ersoy F, Berkel AI, Sanal O, Oktay H: Twenty year follow-up of 160 patients with ataxia-telangiectasia. Turk J Pediatr 33-205-215, 1991
16. 16. Sedgwick RP, Boder E: Ataxia-telangiectasia. In Handbook of Clinical Neurology, JMBV de Jong (ed). Amsterdam, Elsevier, 1991, pp 347-423
17. 17. Siber GR, Schur PH, Aisenherg AC, Weitzman SA, Schiffman G: Correlation between serum IgG2 concentration and the antibody response to bacterial polysaccharide antigens. N Engl J Med 303:178-182, 1080
18. 18. Sanders LA, Rijkers GT, Tenbergen-Meekes AM, Voorhorst-Ogink MM, Zegers BJ: Immunoglobulin isotype-specific antibody responses to pneumococcal polysaccharide vaccine in patients with recurrent bacterial respiratory tract infections. Pediatr Res 37:812-819, 1995
19. 19. Umetsu DT, Amhrosino DM, Quinti I, Siber GR, Geha RS: Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency. N Engl J Med 313:1247-1251, 1985
20. 20. Knutsen A: Patients with IgG subclass and/or selective antibody deficiency to polysaccharide antigens: Initiation of a controlled clinical trial of intravenous immune globulin. J Allergy Clin Immunol 84:640-647, 1989
21. 21. Lane PJ, Maclennon ICM: Impaired IgG2 anti-pneumococcal antibody responses in patients with recurrent infection and normal IgG2 levels but no IgA. Clin Exp Immunol 65:427-433, 1986
22. 22. Rijkers GT, Kuis W, Graeff-Meeder BR, Peeters CCAM, Zegers BJM: Impaired immune response to polysaccharides. N Engl J Med 317:938, 1087
23. 23. Rijkers GT, Sanders LAM, Zegers BJM: Anti-capsular polysaccharide antibody deficiency states. Immunodef 5:1-21, 1903
24. 24. Hidalgo H, Moore C, Leiva L, Sorensen RU: Preimmunization and postimmunization pneumococcal antibody titers in children with recurrent infections. Ann Allergy Asthma Immunol 76:341--346, 1996
25. 25. Raby R, Blaiss M, Gross S, Herrod HG: Antibody response to unconjugated Haemophilus influenzae b and pneumococcal polysaccharide vaccines in children with recurrent infections. J Allergy Clin Immunol 98:451-459, 1996
26. 26. Sanal O, Özyürek H, Ersoy F, Tezcan I, Gariboǧlu S, Berkel AI, Metin A: Antipneumococcal antibody response in healthy Turkish children (in preparation)
27. 27. Sorensen RU, Leiva LE, Giangrosso PA, Butler B, Javier III FC, Saverdote DM, Bradford N, Moore C. Response to a heptavalent conjugate Streptococcus pneumonia vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine. Pediatr Infect Dis J 17:685-601, 1908
28. 28. Zora JA, Silk HJ, Tinkelman DG: Evaluation of postimmunization pneumococcal antibody titers in children with recurrent infections and normal levels of immunoglobulins. Ann Allergy 70:283-288, 1993
29. 20. Schiffman G, Douglas RM, Bonner MJ, Robbins M, Austrian R. A radioimmunoassay for immunologic phenomena in pneumococcal disease and for the antibody response to pneumococcal vaccines. J Immunol Methods 33:133-144, 1980
30. 30. Berkel AI, Tezcan, Ersoy F, Sanal O: Serum immunoglobulin G subclass values in healthy Turkish children and adults. Turk J Pediatr 36:197-204, 1994
31. 31. Eddie SG, Ballas ZK: Anti-pneumococcal antibody response in normal subjects: A meta-analysis. J Allergy Clin Immunol 98:205-215, 1996
32. 32. Musher DM, Luchi MJ, Watson DA, Hamilton R, Baughn RE: Pneumococcal polysaccharide vaccine in young adults and older bronchitics: Determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide. J Infect Dis 161:728-735, 1990
33. 33. De Franco AL: Molecular aspects of B-lymphocyte activation. The antibody response is initiated when B cells bind antigen and are signalled by helper T cells or by certain microbial antigens. Annu Rev Cell Biol 3:143-178, 1987
34. 34. Griffioen AW, Tocbes EAH, Rijkers GT, Claas FHJ, Datema G, Zegers BJM: The amplifier role of T cells in the human in vitro B cell response to type 4 pneumococcal polysaccharide. Immunol Lett 32:265-272, 1992
35. 35. Mosier DE, Subbaro B: Thymus independent antigens:complexity of B-lymphocyte activation revealed. Immunol Today 3:217-222, 1982
36. 36. Mond JJ, Lees A, Snapper CM: T cell-independent antigens type 2. Annu Rev Immunol 13:655-692, 1995
37. 37. Fearon DT, Kelsoe G, Kinet J-P, MacLennan I, Parham P, Rajewsky K: The humoral immune response. In Immunobiology. The Immune System in Health and Disease, 3rd ed, CA Janeway, P Travers (eds). New York, Current Biology/Garland, 1947, pp 8.1-8.54
38. 38. Remold-O'Donnell E, Rosen F, Kenney DM: Defects in Wiskott-Aldrich syndrome: Blood cells. Blood 87:2621-2631, 1996
39. 39. Savitstky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite D, Tagle DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGJ Taylor AMR, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS, Shiloh Y: A single ataxia -telangiectasia gene with a product similar to PI-3 kinase. Science 268:1749-1753, 1995
40. 40. Khanna KK, Yan J, Watters D, Hobson K, Beamish H, Spring K, Shiloh Y, Gatti RA, Lavin M: Defective signalling through the B cell antigen receptor in Epstein-Barr virus transformed ataxia-telangiectasia cells. J Biol Chem 272:9489-9495, 1997